Clinical Trial Update: Dose-Finding Study of PDC31 in Patients With Primary Dysmenorrhea [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 dose-finding study of PDC31 in patients with primary dysmenorrhea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• PDC31

Snippet

Sponsor: PDC Biotech GmbH | Conditions: Dysmenorrhea | Phase 1 | Status: COMPLETED